Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion type Assertion NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_head.
- NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion description "[In colorectal cancer (CRC), evidence shows that expanding RAS testing to analyze more mutations may better predict benefit from anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_provenance.
- NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion evidence source_evidence_literature NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_provenance.
- NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion SIO_000772 25410095 NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_provenance.
- NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion wasDerivedFrom befree-2016 NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_provenance.
- NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion wasGeneratedBy ECO_0000203 NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_provenance.